2-(3-Oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)-n-(4-propoxyphenyl)acetamide, 97%, 100mg

4-(Ethylamino)benzaldehyde, 95.0%, 250mg

METHYL 2-AMINO-5-CHLORO-4-METHOXYBENZOATE, 95.0%, 250mg

5-Bromopyridine-2,3-diol, 95.0%, 25g

1-(2-Chloroethyl)-4-methylpiperazine hydrochloride, 95.0%, 5g

2'-Methyl-3'-nitroacetanilide>98.0%(GC)5g

3-(CYCLOPROPYLMETHOXY)-4-METHOXYBENZOIC ACID, 95.0%, 500mg

2-(2-hydroxyphenyl)-6-methylquinoline-4-carboxylic acid, 95.0%, 1g

TERT-BUTYL TRANS-4-(HYDROXYMETHYL)CYCLOHEXYLCARBAMATE, 95.0%, 100g

Hexaphenyldisilane>97.0%(GC)5g

n-(3-Ethynylphenyl)tetrahydro-2h-pyran-4-amine, 95%, 1g

Monomethacryloxypropylterminated polydimethylsiloxane - asymmetric cSt 150-200 inhibited with BHT, 100g

4-Bromophenyl-(4-fluorobenzyl)ether, 97.0%, 100mg